References
- National Institutes of Health, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. NIH publication No. 98–4080, November 1997
- Elliott WJ, Toth SJ, Stemer A, et al. Detection, treatment, and control of adult hypertension in northwest Indiana: Ispat Inland/United Steelworkers of America Health Care Network. Am J Hypertens 1999; 12(8 Pt 1): 830–4
- Berlowitz DR, Ash AS, Hickey EC, et al. Inadequate management of blood pressure in a hypertensive population. N Engl J Med 1998; 339(27): 1957–63
- UK Prospective Diabetes Study (UKPDS) Group. Cost-effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 1998; 317(7160): 720–6
- Gerber JC, Stewart DL. Prevention and control of hypertension and diabetes in an underserved population through community outreach and disease management: a plan of action. J Assoc Acad Minor Phys 1998; 9(3): 48–52
- American Heart Association Expert Panel. The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation 1997; 95(4): 1085–90
- Lenfant C. Task force on behavioral research in cardiovascular, lung, and blood health and disease. Circulation 1998; 98(4): 281–6
- Weir MR, Prisant LM, Papademetriou V, et al. Antihypertensive therapy and quality of life: influence of blood pressure reduction, adverse events, and prior antihypertensive therapy. Am J Hypertens 1996; 9: 854–9
- Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 1998; 351: 1755–62
- UK Prospective Diabetes Study (UKPDS) Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998; 317(7160): 707–13
- Hosie J, Wiklund I. Managing hypertension in general practice: can we do better? J Human Hypertens 1995; 9(Suppl 2): 515–8
- Larme AC, Pugh JA. Attitudes of primary care providers towards diabetes: barriers to guideline implementation. Diabetes Care 1998; 21: 1391–6
- Jones JK, Gorkin L, Lian JF, et al. Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 1995; 311: 293–5
- Rizzo JA, Robert-Simons W. Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clin Ther 1997; 19(6): 1446–57
- Elliott WJ, Weir DR, Black HR. Cost-effectiveness of the lower treatment goal (of JNC VI) for diabetic hypertensives. Arch Intern Med 2000; 160 (in press)
- Sheinfeld GR, Bakris GL. Benefits of combination angiotensin-converting enzyme inhibitor and calcium antagonist therapy for diabetic patients. Am J Hypertens 1999; 12: 80–5S